Beneficial effects of NO-releasing derivative of flurbiprofen (HCT-1026) in rat model of vascular injury and restenosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 2, 2002, Pages 263-267

  Maffia, Pasquale ^a   Ianaro, Angela ^a   Sorrentino, Raffella ^a   Lippolis, Laura ^a   Maiello, Francesco M ^a   Del Soldato, Piero ^a   Ialenti, Armando ^a   Cirino, Giuseppe ^a  

^a Dipto di Farmacologia Sperimentale   (Italy)

Author keywords

Balloon angioplasty; HCT 1026; Nitric oxide; NSAIDs; Restenosis

Indexed keywords

FLURBIPROFEN; FLURBIPROFEN 4 NITROXYBUTYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD LEVEL; BLOOD PRESSURE; BLOOD VESSEL INJURY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RAT; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADMINISTRATION, ORAL; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAROTID ARTERIES; CORONARY RESTENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLURBIPROFEN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; STOMACH DISEASES; TUNICA INTIMA;

EID: 0036159486     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0202.104064     Document Type: Article

References (32)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Cell biology of atherosclerosis
3. Oxidation of LDL by nitric oxide and its modification by superoxides in macrophage and cell free systems
4. Nitric oxide (NO) donor molecules: Effect of NO release rate on vascular smooth muscle cell proliferation in vitro
5. The endothelium as regulator of vascular smooth muscle proliferation
6. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors
7. Nitric oxide synthase induces macrophages death by apoptosis
8. Bcl-2 protects macrophages from nitric oxide induced apoptosis
9. A nitric oxide donor (spermine NONOate) prevents the formation of neointima in rat carotid artery
10. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced endothelial injury
11. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat
12. Opposite effects of flurbiprofen and the nitroxybutyl ester of flurbiprofen on apoptosis in cultured guinea-pig gastric mucous cells
13. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty
14. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer
15. Measurement of blood pressure in unanaesthetized rats and mice
16. Tumordependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice
17. Restenosis a challenge for pharmacology
18. L-arginine inhibits balloon catheter-induced intimal hyperplasia
19. Continuous perivascular L-arginine delivery increases total vessel area and reduced neointimal thickening after experimental balloon dilatation
20. Balloon injury and interleukin 1β induce nitric oxide synthase activity in rat carotid arteries
21. Arterial smooth muscle cells expresses nitric oxide in response to endothelial injury
22. Functional evidence that balloon angioplasty results in transient nitric oxide induction
23. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene
24. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats
25. Recombinant endothelial nitric oxide synthase transduced human saphenous veins: Gene therapy to augment nitric oxide production in bypass conduits
26. Vascular gene transfer of the human inducible nitric oxide synthase: Characterization of activity and effects on myointimal hyperplasia
27. Effect of direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty: The ACCORD study
28. A perspective on the potential problems with aspirin as an antithrombotic agent: A comparison of studies in an animal model with clinical trials
29. Injury-coupled induction of endothelial eNOS and COX-2 genes: A paradigm for thromboresistant gene therapy
30. Sulindac inhibits neointimal formation after arterial injury in wild type and apolipoprotein E-deficient mice
31. Flurbinitroxy-butylester: A novel anti-inflammatory drug has enhanced antithrombotic activity
32. Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties